$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Stable complexes of poorly soluble compounds in ionic polymers 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-047/32
  • A61K-047/38
출원번호 US-0391060 (1999-09-07)
발명자 / 주소
  • Antonio A. Albano
  • Wantanee Phuapradit
  • Harpreet K. Sandhu
  • Navnit Hargovindas Shah
출원인 / 주소
  • Hoffmann-La Roche Inc.
대리인 / 주소
    George W. Johnston
인용정보 피인용 횟수 : 39  인용 특허 : 8

초록

Stable water-insoluble complexes of poorly soluble compounds molecularly dispersed in water-insoluble ionic polymers are disclosed. Useful insoluble ionic polymers have a molecular weight greater than about 80,000 D and a glass transition temperature equal to or greater than about 50.degree.. The co

대표청구항

1. A pharmaceutical composition comprising a carrier and a water-soluble complex of a therapeutically active, stable amorphous compound selected from the group consisting of [EQU3][EQU4]and a water-insoluble ionic polymer that has a molecular weight greater than about 80,000 D, a glass transition te

이 특허에 인용된 특허 (8)

  1. Bosies Elmar,DEX ; Esswein Angelika,DEX ; Grams Frank,DEX ; Krell Hans-Willi,DEX ; Menta Ernesto,ITX, Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds.
  2. Chen Li ; Guthrie Robert William ; Huang Tai-Nang ; Sidduri Achyutharao ; Tilley Jefferson Wright ; Hull Kenneth Gregory, N-aroylphenylalanine derivative VCAM-1 inhibitors.
  3. Kelm Gary R. (Cincinnati OH) Dobrozsi Douglas J. (Cincinnati OH), Solid dispersion compositions of tebufelone.
  4. Davis Peter D.,GBX ; Hill Christopher H.,GBX ; Lawton Geoffrey,GBX, Substituted pyrroles.
  5. Dhingra Urvashi Hooda ; Huryn Donna Mary ; Ke June ; Weber Giuseppe Federico, Substituted pyrroles.
  6. Liversidge Gary G. (West Chester PA) Liversidge Elaine (West Chester PA) Sarpotdar Pramod P. (Malvern PA), Surface modified anticancer nanoparticles.
  7. Martin Frederick H. (West Chazy NY) Tsuk Andrew G. (Plattsburgh NY), Therapeutic compositions with enhanced bioavailability.
  8. Li Chun ; Wallace Sidney ; Yu Dong-Fang ; Yang David J., Water soluble paclitaxel prodrugs.

이 특허를 인용한 특허 (39)

  1. Boruah, Anima; Alikunju, Shanavas, 5-benzylaminomethyl-6-aminopyrazolo [3, 4 -B] pyridine derivatives as cholesteryl ester-transfer protein (CETP) inhibitors useful for the treatment of atherosclerosis.
  2. Antonio A. Albano ; Wantanee Phuapradit ; Harpreet K. Sandhu ; Navnit Hargovindas Shah, Amorphous form of cell cycle inhibitor having improved solubility and bioavailability.
  3. Antonio A. Albano ; Wantanee Phuapradit ; Harpreet K. Sandhu ; Navnit Hargovindas Shah, Amorphous form of cell cycle inhibitor having improved solubility and bioavailability.
  4. Antonio A. Albano ; Wantanee Phuapradit ; Harpreet K. Sandhu ; Navnit Hargovindas Shah, Amorphous form of cell cycle inhibitor having improved solubility and bioavailability.
  5. Antonio A. Albano ; Wantanee Phuapradit ; Harpreet K. Sandhu ; Navnit Hargovindas Shah, Amorphous form of cell inhibitor having improved solubility and bioavailability.
  6. Baruah, Anima; De, Dibyendu; Khanna, Ish Kumar; Pillarisetti, Sivaram; Maitra, Santanu; Alexander, Christopher W.; Sreenu, Jennepalli; Dager, Indu; Alikunju, Shanavas, Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors.
  7. Perry, David; Maples, Kirk R.; Bellinger-Kawahara, Carolyn, Boron-containing compounds and methods of use.
  8. Desai, Dipen; Diodone, Ralph; Go, Zenaida; Ibrahim, Prabha N.; Iyer, Raman; Mair, Hans-Juergen; Sandhu, Harpreet K.; Shah, Navnit H.; Visor, Gary; Wyttenbach, Nicole; Lauper, Stephan; Pudewell, Johannes; Wierschem, Frank, Compositions and uses thereof.
  9. Desai, Dipen; Diodone, Ralph; Go, Zenaida; Ibrahim, Prabha N.; Iyer, Raman; Mair, Hans-Juergen; Sandhu, Harpreet K.; Shah, Navnit H.; Visor, Gary; Wyttenbach, Nicole; Lauper, Stephan; Pudewell, Johannes; Wierschem, Frank, Compositions and uses thereof.
  10. Ibrahim, Prabha N.; Artis, Dean R.; Bremer, Ryan; Habets, Gaston; Mamo, Shumeye; Nespi, Marika; Zhang, Chao; Zhang, Jiazhong; Zhu, Yong-Liang; Zuckerman, Rebecca; West, Brian; Suzuki, Yoshisa; Tsai, Jianming; Hirth, Klaus-Peter; Bollag, Gideon; Spevak, Wayne; Cho, Hanna; Gillette, Samuel J.; Wu, Guoxian; Zhu, Hongyao; Shi, Shenghua, Compounds and methods for kinase modulation, and indications therefor.
  11. Ibrahim, Prabha N.; Artis, Dean R.; Bremer, Ryan; Mamo, Shumeye; Zhang, Chao; Zhang, Jiazhong; Tsai, Jianming; Hirth, Klaus-Peter; Bollag, Gideon; Spevak, Wayne; Cho, Hanna; Gillette, Samuel J.; Shi, Shenghua, Compounds and methods for kinase modulation, and indications therefor.
  12. Ibrahim, Prabha; Zhang, Chao; Spevak, Wayne; Zhang, Jiazhong; Wu, Guoxian; Lin, Jack; Cho, Hanna; Nespi, Marika; Shi, Songyuan; Ewing, Todd; Zhang, Ying, Compounds and methods for kinase modulation, and indications therefor.
  13. Wu, Guoxian; Spevak, Wayne; Shi, Songyuan; Cho, Hanna; Ibrahim, Prabha N.; Zhang, Chao; Shi, Shenghua; Zhou, Yong; Artis, Dean; Zhang, Jiazhong, Compounds and methods for kinase modulation, and indications therefor.
  14. Wu, Guoxian; Zhang, Jiazhong; Zhu, Yong-Liang; Zhang, Chao; Ibrahim, Prabha N.; Shi, Songyuan; Spevak, Wayne; Artis, Dean R.; Tsai, James, Compounds and methods for kinase modulation, and indications therefor.
  15. Wu, Guoxian; Zhang, Jiazhong; Zhu, Yong-Liang; Zhang, Chao; Ibrahim, Prabha N.; Shi, Songyuan; Spevak, Wayne; Artis, Dean R.; Tsai, James, Compounds and methods for kinase modulation, and indications therefor.
  16. Zhang, Jiazhong; Ibrahim, Prabha N.; Bremer, Ryan; Spevak, Wayne; Cho, Hanna, Compounds and methods for kinase modulation, and indications therefor.
  17. Zhang, Jiazhong; Ibrahim, Prabha N.; Artis, Dean R.; Bremer, Ryan; Wu, Guoxian; Zhu, Hongyao; Nespi, Marika; Zhang, Chao, Compounds modulating c-fms and/or c-kit activity.
  18. Ibrahim, Prabha N.; Artis, Dean R.; Bremer, Ryan; Wu, Guoxian; Zhu, Hongyao; Nespi, Marika; Zhang, Chao; Zhang, Jiazhong, Compounds modulating c-fms and/or c-kit activity and uses therefor.
  19. Zhang, Jiazhong; Ibrahim, Prabha N.; Artis, Dean R.; Bremer, Ryan; Wu, Guoxian; Nespi, Marika; Zhang, Chao, Compounds modulating c-fms and/or c-kit activity and uses therefor.
  20. Zhang, Jiazhong; Ibrahim, Prabha N.; Bremer, Ryan, Compounds modulating c-fms and/or c-kit activity and uses therefor.
  21. Zhang, Jiazhong; Ibrahim, Prabha N.; Bremer, Ryan, Compounds modulating c-fms and/or c-kit activity and uses therefor.
  22. Naringrekar, Gandha V.; Arnold, Kristin A.; Erkoboni, David, Controlled-release formulations, method of manufacture, and use thereof.
  23. Naringrekar, Gandha V.; Arnold, Kristin A.; Erkoboni, David, Controlled-release formulations, method of manufacture, and use thereof.
  24. Breimer, Lars Holger; Dhingra, Kapil; Dhingra, Urvashi Hooda; Ritland, Steve, Method for cancer therapy.
  25. Beyerinck, Ronald A.; Deibele, Heather L. M.; Dobry, Dan E.; Ray, Roderick J.; Settell, Dana M.; Spence, Ken R., Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus.
  26. Beyerinck, Ronald A.; Diebele, Heather L. M.; Dobry, Dan E.; Ray, Roderick J.; Settell, Dana M.; Spence, Ken R., Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus.
  27. Moolman, Francis Sean; Rolfes, Heidi; Van Der Merwe, Thilo Lothar, Method of encapsulating an active substance.
  28. Djordjevic, Jelena; Bommana, Murali Mohan; Phuapradit, Wantanee; Shah, Navnit H.; Pizzo, Christopher A., Orally disintegrating tablet formulation for enhanced bioavailability.
  29. Bartsch, Pierre; Cataldo, Didier; Endele, Richard; Evrard, Brigitte; Foidart, Jean-Michel; Krell, Hans-Willi; Zimmermann, Gerd, Pharmaceutical compositions of pyrimidine-2,4,6-triones.
  30. Mehta, Deepak B.; Corbo, Michael, Process for coating stents and other medical devices using super-critical carbon dioxide.
  31. Hildbrand, Stefan; Mair, Hans-Juergen; Radinov, Roumen Nikolaev; Ren, Yi; Wright, James Anderson, Process for the manufacture of pharmaceutically active compounds.
  32. Kawasaki, Junichi; Nakamura, Atsuya; Kamada, Naoki, Solid dispersion comprising amorphous cilostazol.
  33. Ibrahim, Prabha N.; Visor, Gary Conard; Kuang, Shan-Ming; Zhao, Baoshu; Diodone, Ralph; Fähnrich, Karsten; Schwitter, Urs, Solid forms of a pharmaceutically active substance.
  34. Ibrahim, Prabha N.; Visor, Gary Conard; Kuang, Shan-Ming; Zhao, Baoshu; Diodone, Ralph; Fähnrich, Karsten; Schwitter, Urs, Solid forms of a pharmaceutically active substance.
  35. Baruah, Anima; De, Dibyendu; Khanna, Ish Kumar; Pillarisetti, Sivaram; Maitra, Santanu; Alexander, Christopher W.; Sreenu, Jennepalli; Dager, Indu; Alikunju, Shanavas, Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors.
  36. Baruah, Anima; De, Dibyendu; Khanna, Ish Kumar; Pillarisetti, Sivaram; Maitra, Santanu; Alexander, Christopher W.; Sreenu, Jennepalli; Dager, Indu; Alikunju, Shanavas, Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors.
  37. Boruah, Anima; Alikunju, Shanavas, Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (CETP) inhibitors.
  38. Ibrahim, Prabha N., Synthesis of heterocyclic compounds.
  39. Ibrahim, Prabha N., Synthesis of heterocyclic compounds.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로